Michael Boyiadzis
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia (NCT03291353) | Michael Boyiadzis | 2017-10-17 |
Track Michael Boyiadzis automatically
Every clearance here is in the API, with alerts when new ones post.